News Event » Business News »
Wall Street Journal: 3rd UPDATE: Shire To Buy Germany's Jerini, Boosting Portfolio
Event summary
Thursday said it's acquiring German biotech company Jerini AG (JI4.XE) for EUR328 million, in a move that will boost its portfolio of drugs for rare genetic diseases. The acquisition will bring in Firazyr, an experimental drug that treats acute ...
This event is older than two weeks and is no longer active. Some links older than 2 weeks could be broken. Report a new related event!
All news stories
Source:
International Business Times
| Jul 03, 8:23 AM
Jerini makes Firazyr, an orphan drug treatment for hereditary angioedema, a rare genetic disorder which affects the blood vessels, causing rapid swelling of the hands, feet and face, etc...Firazyr is expected to be approved in Europe in the 2008 ...
Source:
Uinta County News
| Jul 03, 6:09 AM
Thursday said it's acquiring German biotech company Jerini AG (JI4.XE) for EUR328 million, in a move that will boost its portfolio of drugs for rare genetic diseases. The acquisition will bring in Firazyr, an experimental drug that treats acute ...
Site Links
Contributions
- Sign up, and add your voice by contributing to allvoices
- Report Your News
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
